HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Targeted agents changing treatment of metastatic renal cell carcinoma
-
- Should new targeted molecular agents be used as neoadjuvant therapy for metastatic renal cell carcinoma?
- William Stewart Halsted: surgical pioneer
- A rare B-cell lymphoproliferative disorder: hairy cell leukemia Wajeeha Razaq, MD
- Prostate cancer — a few small steps, much to be done Donald L. Trump, MD, FACP
- Do not take this grant for granted Sikander Ailawadhi, MD
- Paging Dr. Jazz Arthur Topilow, MD, FACP
- BMI linked to overall survival in locally advanced breast cancer
- Combination approach to mediastinal staging effective
-
- Discrepancies in survival between scalp/neck melanoma and melanoma at other sites
- Genetic alterations predict lung cancer reccurrence
- Number of hospitalized patients at risk for VTE not receiving recommended prophylaxis
- Ifosfamide neurotoxicity and potential treatment with methylene blue Lisa K. Lohr, PharmD, BCPS, BCOP